2.5896

8.80% -0.2504

Cdt Equity Inc (CDT)

Overview News Price History Why CDT Down? Discussions Forecast

Cdt Equity Inc stock is traded at $2.5896, with a volume of 76,592. It is down -8.80% in the last 24 hours and down -52.06% over the past month. CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Previous Close:

$2.84

Open:

$2.78

24h Volume:

76,592

Relative Volume:

0.11

Market Cap:

$3.84M

Revenue:

Net Income/Loss:

$-4.21M

P/E Ratio:

-47.26

EPS:

-0.0548

Net Cash Flow:

1W Performance:

-15.64%

1M Performance:

-52.06%

6M Performance:

-95.98%

1Y Performance:

-99.76%

1-Day Range:

$2.392

$2.78

1-Week Range:

$2.392

$3.2198

52-Week Range:

$2.392

$2,198.40

Cdt Equity Inc Stock (CDT) Company Profile

Name

Cdt Equity Inc

Sector

Healthcare (1139)

Industry

Biotechnology (635)

Phone

(646) 491 9132

Address

4851 TAMIAMI TRAIL NORTH, NAPLES

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CDT's Discussions on Twitter

Compare CDT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CDT Cdt Equity Inc	2.53	3.84M	0	-4.21M	0	-0.0548
VRTX Vertex Pharmaceuticals Inc	425.41	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.28	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	432.39	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	821.96	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	184.19	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Cdt Equity Inc Stock (CDT) Latest News

Oct 25, 2025

Analyzing CDT Equity (NASDAQ:CDT) and Chugai Pharmaceutical (OTCMKTS:CHGCY) - Defense World

Oct 25, 2025

Oct 22, 2025

CDT Equity acquires 9.25 bitcoin for $1 million By Investing.com - Investing.com Canada

Oct 17, 2025

CDT Equity increases bitcoin holding - MSN

Oct 17, 2025

US-listed company CDT Equity increases its holdings by approximately 9.25 bitcoins - Bitget

Oct 17, 2025

CDT Equity Inc. Acquires $1 Million in Bitcoin as Part of Cryptocurrency Treasury Reserve Strategy - Quiver Quantitative

Oct 17, 2025

Cdt Equity Inc buys 9.256 bitcoin for $1,005,000 - MarketScreener

Oct 17, 2025

CDT Equity Increases Bitcoin Holding - The Manila Times

Oct 17, 2025

CDT Equity Inc Buys 9.256 Bitcoin For $1,005,000 - TradingView

Oct 17, 2025

SRx Health Solutions Received NYSE American Notification Letter Regarding Stockholders' Equity Deficiency - The Manila Times

Oct 17, 2025

9.25648743 BTC acquired: CDT Equity boosts treasury holdings to 17.9090111 BTC - Stock Titan

Oct 17, 2025

Oct 15, 2025

Conduit Pharmaceuticals Announces Reverse Stock Split - MSN

Oct 15, 2025

CDT Environmental Technology Investment Holdings Limited stock prediction for this weekWeekly Gains Report & Community Consensus Trade Alerts - newser.com

Oct 15, 2025

Oct 14, 2025

Equity Bancshares: Q3 Earnings Snapshot - kens5.com

Oct 14, 2025

Oct 10, 2025

CDT Equity Inc trading halted, news pending - MSN

Oct 10, 2025

CDT Equity announces 1-for-8 reverse stock split effective October 10 - MSN

Oct 10, 2025